Epstein Files Search

EFTA00506157Set 9

46p3,296w

EFTA00506163 Ovation Therapeutics DACARI C API I AL I-LC7 EFTA00506164 Ovation Therapeutics Monoclonal Polyclonal • Multivalency Increased avidity Increased potency Increased effector function DACARTGAPIIAL LLC, EFTA00506165 Ovation Therapeutics • Next-generation ... antibody therapy • Monoclonals are big ($26B in 2010), polyclonals are better • Polyclonal production available in Q4, 2012 • "Killer app" in hospital acquired infections $25M needed to reach $200M enterprise value ... Ovation Therapeutics ■ What Is It? Ovation has a proprietary platform to create next-generation polyclonal antibody therapeutics and improved monoclonal antibody therapeutics. ■ How Does It Work? Ovation's genetically modified

https://www.justice.gov/epstein/files/DataSet%209/EFTA00506157.pdf

EFTA00506107Set 9

49p3,212w

CArt !AL LLC2 EFTA00506136 Products Deposited in Eggs DAGAI,T,APITAL LLC EFTA00506137 Polyclonal Antibodies Monoclonal Polyclonal • In Di.Cnar Cnrirni ttc in k Multivalency Increased avidity ncrea sed p efroetectnocry ... several multi-billion dollar markets. • Huge market opportunity • Enzyme Replacement Therapy - $15.0 B • Polyclonal Antibodies: c. difficile, MRSA - $10.0 B • Factor VII Deficiency - $5.8 B $25M needed to reach $200M ... novel manufacturing methods for the production of therapeutic enzymes, and human sequence monoclonal and polyclonal antibodies. • How Does It Work? OvationBio selects the most active and effective protein

https://www.justice.gov/epstein/files/DataSet%209/EFTA00506107.pdf

EFTA02295528Set 11

49p3,041w

EFTA_R1_01138831 EFTA02295557 Products Deposited in Eggs ovItluCt EFTA_R1_01136932 EFTA02295558 Polyclonal Antibodies If? Monoclonal Polyclonal Multivalency Increased avidity Increased potency Increased effector function DAAIRTCP,FIT/NA ... several multi-billion dollar markets. Huge market opportunity • Enzyme Replacement Therapy - $15.0 B • Polyclonal Antibodies: c. difficile, MRSA - $10.0 B • Factor VII Deficiency - $5.8 B $25M needed to reach $200M ... novel manufacturing methods for the production of therapeutic enzymes, and human sequence monoclonal and polyclonal antibodies. • How Does It Work? OvationBio selects the most active and effective protein

https://www.justice.gov/epstein/files/DataSet%2011/EFTA02295528.pdf

EFTA02082357Set 10

2015-03-053p897w

early work. Somehow OvationBio is what I thought you would find most interesting. Producing polyclonal antibodies from genetically modified chickens could solve one of the biggest medical problems

https://www.justice.gov/epstein/files/DataSet%2010/EFTA02082357.pdf

EFTA00351818Set 9

2015-03-063p768w

early work. Somehow OvationBio is what I thought you would find most interesting. Producing polyclonal antibodies from genetically modified chickens could solve one of the biggest medical problems

https://www.justice.gov/epstein/files/DataSet%209/EFTA00351818.pdf

EFTA00351823Set 9

2015-03-062p784w

early work. Somehow OvationBio is what I thought you would find most interesting. Producing polyclonal antibodies from genetically modified chickens could solve one of the biggest medical problems

https://www.justice.gov/epstein/files/DataSet%209/EFTA00351823.pdf

EFTA00351821Set 9

2015-03-062p790w

early work. Somehow OvationBio is what I thought you would find most interesting. Producing polyclonal antibodies from genetically modified chickens could solve one of the biggest medical problems

https://www.justice.gov/epstein/files/DataSet%209/EFTA00351821.pdf

EFTA02082320Set 10

2015-03-163p842w

early work. Somehow OvationBio is what I thought you would find most interesting. Producing polyclonal antibodies from genetically modified chickens could solve one of the biggest medical problems

https://www.justice.gov/epstein/files/DataSet%2010/EFTA02082320.pdf

EFTA02082969Set 10

2015-03-063p809w

early work. Somehow OvationBio is what I thought you would find most interesting. Producing polyclonal antibodies from genetically modified chickens could solve one of the biggest medical problems

https://www.justice.gov/epstein/files/DataSet%2010/EFTA02082969.pdf

EFTA02713009Set 11

2014-04-107p5,082w

days p.i. ther work with a severely attenuated HSV-I strain (in1814) With polyclonal HSV-I antiserum (Dako, Carpinteria, Calif.) in immunocompromised severe combined immunodeficiency being used, virus-infected nerve

https://www.justice.gov/epstein/files/DataSet%2011/EFTA02713009.pdf

EFTA02083923Set 10

2015-03-064p824w

early work. Somehow OvationBio is what I thought you would find most interesting. Producing polyclonal antibodies from genetically modified chickens could solve one of the biggest medical problems

https://www.justice.gov/epstein/files/DataSet%2010/EFTA02083923.pdf

EFTA00692665Set 9

2013-02-143p579w

week: view our author uidelines and submit now to for rapid, hassle- free publication. Polyclonal free light chains: a it biomarker of inflammatory disease or Submit your treatment target? article

https://www.justice.gov/epstein/files/DataSet%209/EFTA00692665.pdf

EFTA02082294Set 10

2015-03-163p937w

early work. Somehow OvationBio is what I thought you would find most interesting. Producing polyclonal antibodies from genetically modified chickens could solve one of the biggest medical problems

https://www.justice.gov/epstein/files/DataSet%2010/EFTA02082294.pdf

EFTA02082281Set 10

2015-03-163p829w

early work. Somehow OvationBio is what I thought you would find most interesting. Producing polyclonal antibodies from genetically modified chickens could solve one of the biggest medical problems

https://www.justice.gov/epstein/files/DataSet%2010/EFTA02082281.pdf